BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 96 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,551,528 | -12.0% | 246,463 | +0.2% | 0.01% | -16.7% |
| Q2 2023 | $4,037,825 | -5.5% | 245,909 | -3.9% | 0.01% | 0.0% |
| Q1 2023 | $4,273,947 | +9.3% | 255,771 | +0.9% | 0.01% | 0.0% |
| Q4 2022 | $3,910,136 | -8.6% | 253,407 | -11.6% | 0.01% | -14.3% |
| Q3 2022 | $4,279,000 | -6.3% | 286,598 | +3.1% | 0.01% | 0.0% |
| Q2 2022 | $4,569,000 | -15.1% | 278,100 | +3.6% | 0.01% | 0.0% |
| Q1 2022 | $5,383,000 | -18.0% | 268,341 | +3.7% | 0.01% | -22.2% |
| Q4 2021 | $6,563,000 | +11.4% | 258,807 | +18.5% | 0.01% | 0.0% |
| Q3 2021 | $5,893,000 | +3.1% | 218,420 | +10.5% | 0.01% | 0.0% |
| Q2 2021 | $5,715,000 | +20.9% | 197,614 | +10.0% | 0.01% | +12.5% |
| Q1 2021 | $4,727,000 | +30.1% | 179,722 | +41.7% | 0.01% | +33.3% |
| Q4 2020 | $3,634,000 | +7.7% | 126,838 | -10.3% | 0.01% | -14.3% |
| Q3 2020 | $3,373,000 | +23.6% | 141,447 | +8.4% | 0.01% | +16.7% |
| Q2 2020 | $2,730,000 | +206.7% | 130,546 | +164.7% | 0.01% | +200.0% |
| Q1 2020 | $890,000 | – | 49,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |